Sponsored by:

Molecular Imaging

Novel SST2-PET tracer shows promise in patients with NETs
By Will Morton
With a half-life of 3.3 hours, cyclotron-produced Cu-61 NODAGA-LM3 could allow delayed imaging and centralized distribution.
June 25, 2026
Maximum intensity projections showing biodistribution of Cu-61 NODAGA-LM3 (146 MBq) in a patient with a metastatic non-functional NET of the pancreas G2 (Ki-67: 5%) with lymph node, hepatic, osseous, and peritoneal as well as ovarian metastases. PET performed a 1-hour, 3-hours, and 18-hours post-injection show high and prolonged tumor uptake and excellent image contrast, with low uptake in the liver, intestinal tract, and other non-target organs.
SNMMI mourns passing of Twyla Bartel
By AuntMinnie.com staff writers
The SNMMI is mourning the passing of one of its leading members.
June 23, 2026
Twyla Bartel, DO
AdvanCell establishes U.S. headquarters, manufacturing facility
By AuntMinnie.com staff writers
The Andover site will support development and future commercialization of ADVC001.
June 22, 2026
Nuclearmedicine
New PET tracer shows promise for guiding pancreatic cancer therapy
By Will Morton
The radiotracer is designed to identify pancreatic tumors eligible for paired therapy with cancer-killing actinium-225 (Ac-225) NMT25.
June 19, 2026
Transaxial Zr-89 NMK89 PET/CT images 1, 24, 72, and 168 hours after injection showing increasing uptake in pancreatic tail adenocarcinoma. Maximum standard uptake value (SUV) in the pancreatic mass is 14 at 168 hours post-injection (crosshairs). PET SUV scale used for windowing was 0 to 10.
$9M grant invests in 'next generation' of CAA scientists
By AuntMinnie.com staff writers
Project will combine advanced brain imaging with new molecular biomarkers and innovative experimental models.
June 19, 2026
Dollars Pile
Curium, Lantheus win patent dispute over lutetium-177 dotatate products
By AuntMinnie.com staff writers
June 17 ruling may increase competition in the U.S. for Lutathera.
June 19, 2026
Gavel Money Lawsuit Social
PET/CT could improve margin assessment for breast tumors
By Amerigo Allegretto
Specimen PET/CT imaging outperforms routine intraoperative margin assessment in breast tumors.
June 19, 2026
Pet Scan Patient 400 (1)
Niowave, Ratio Therapeutics ink Ac-225 supply agreement
By AuntMinnie.com staff writers
Companies plan for Actinium-225 clinical trial activities.
June 16, 2026
Atom Nuclear Lab Thumb
New immuno-PET tracer shows promise in prostate cancer
By Will Morton
Compared to conventional imaging, Zr-89 DFO-YS5 PET identified additional lesions.
June 15, 2026
A 74-year-old patient with metastatic prostate cancer with a positive left iliac wing lesion (SUVmax of 35.02) seen on (A) Zr-89 DFO-YS5 PET maximum projection image (MIP) and (B) PET/CT (red arrows). The lesion was graded 5 on PET but was not visible on CT (D) or (D) technitium-99 MDP bone scan.
Xeos touts intraoperative PET/CT study
By AuntMinnie.com staff writers
Investigators from Vanderbilt University Medical Center in Nashville, TN, used the system to perform specimen imaging immediately following resection.
June 12, 2026
Cancertarget
Canada gets first Biograph One PET/MRI scanner
By AuntMinnie.com staff writers
Researchers plan to use the scanner to study cancer, stroke, neurological disorders.
June 12, 2026
The Biograph One PET/MRI scanner.
SNMMI awards $530K in Mars Shot grants
By AuntMinnie.com staff writers
The SNMMI Mars Shot Research Fund was established in 2023.
June 11, 2026
Am 2020 10 15 21 42 4157 Money Bag Grant Award 400
Page 1 of 630
Next Page